查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1878818

微創活體組織切片技術市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、技術、循環生物標記、應用、最終用戶、地區和競爭格局細分，2020-2030年預測

Minimally Invasive Biopsy Techniques Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Offered, By Technique, By Circulating Biomarker, By Application, By End User, By Region, By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球微創切片技術市場規模為137.5億美元，預計2030年將以10.30%的複合年成長率成長至247.6億美元。微創切片技術是指與傳統手術切片相比，在減少物理創傷、縮短恢復時間和降低併發症風險的同時，取得組織或體液樣本的診斷程序。推動該市場成長的關鍵因素包括：全球癌症和其他需要明確組織診斷的疾病發生率不斷上升；患者越來越傾向於選擇創傷性較小的醫療干預措施；以及影像引導和設備精度方面的持續技術進步。這些創新提高了樣本採集的準確性和效率，從而支持更廣泛的臨床應用。

市場概覽
預測期 2026-2030
2024年市場規模 137.5億美元
2030年市場規模 247.6億美元
2025-2030年複合年成長率 10.3%
成長最快的細分市場 液體活體組織切片
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球微創切片技術市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型（測試、試劑盒及耗材、儀器）
    • 按技術分類（液體活體組織切片、光學活體組織切片、刷取活體組織切片、色素性病變檢測、其他）
    • 透過循環生物標記（循環腫瘤細胞 (CTC)、遊離 DNA (cfDNA)、循環腫瘤 DNA (ctDNA)、細胞外囊泡、其他）
    • 依應用領域（臨床、治療）
    • 依最終使用者（醫院和診所、門診中心、學術和研究機構）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美微創切片技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲微創切片技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區微創切片技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲微創切片技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲微創切片技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球微創切片技術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Guardant Health, Inc.
  • Veracyte, Inc.
  • Myriad Genetics, Inc.
  • Biocept, Inc.
  • NeoGenomics Laboratories, Inc.
  • Adaptive Biotechnologies Corporation

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 12951

The Global Minimally Invasive Biopsy Techniques Market, valued at USD 13.75 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 24.76 Billion by 2030. Minimally invasive biopsy techniques involve diagnostic procedures designed to obtain tissue or fluid samples with reduced physical trauma, shorter recovery times, and decreased complication risks compared to conventional surgical biopsies. Key drivers propelling this market's growth include the rising global prevalence of cancer and other conditions necessitating definitive tissue diagnosis, an increasing patient inclination towards less invasive medical interventions, and continuous technological advancements in imaging guidance and device precision. These innovations enhance the accuracy and efficiency of sample collection, supporting broader clinical

Market Overview
Forecast Period2026-2030
Market Size 2024USD 13.75 Billion
Market Size 2030USD 24.76 Billion
CAGR 2025-203010.3%
Fastest Growing SegmentLiquid Biopsy
Largest MarketNorth America

Key Market Drivers

The increasing global burden of cancer and chronic diseases stands as a primary catalyst for the expansion of the minimally invasive biopsy techniques market. As diagnostic needs escalate for a growing patient population, the imperative for accurate and timely tissue sampling intensifies. These techniques offer a less intrusive yet highly effective method for obtaining critical diagnostic information, directly responding to the rising disease prevalence. According to the World Health Organization (WHO), on February 1, 2024, in "Global cancer burden growing, amidst mounting need for services," there were an estimated 20 million new cancer cases globally in 2022, underscoring the vast and continuous demand for robust diagnostic interventions. This widespread incidence drives healthcare systems to prioritize efficient and patient-friendly diagnostic pathways.

Key Market Challenges

The inherent technical complexity and demanding learning curve associated with specialized minimally invasive biopsy procedures represent a significant challenge to the growth of the Global Minimally Invasive Biopsy Techniques Market. These procedures require extensive training and substantial expertise from healthcare professionals to ensure optimal diagnostic yield and patient safety. This stringent requirement limits the number of practitioners qualified to perform these advanced techniques, directly impeding broader clinical adoption.

Key Market Trends

Liquid biopsy dominance and expansion represents a pivotal trend reshaping cancer diagnostics by offering minimally invasive methods for disease detection and surveillance. These blood-based tests analyze circulating tumor DNA and other biomarkers, providing a less intrusive alternative to conventional tissue biopsies, especially beneficial for inaccessible tumors or for continuous monitoring of treatment efficacy. The Association for Molecular Pathology and the College of American Pathologists collectively published 13 best practice recommendations for validating and reporting clinical circulating tumor DNA assays, indicating a growing formalization and clinical acceptance of these techniques in October 2023. This advancement facilitates earlier detection of recurrence and precise assessment of therapeutic response.

Key Market Players

  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Guardant Health, Inc.
  • Veracyte, Inc.
  • Myriad Genetics, Inc.
  • Biocept, Inc.
  • NeoGenomics Laboratories, Inc.
  • Adaptive Biotechnologies Corporation

Report Scope:

In this report, the Global Minimally Invasive Biopsy Techniques Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Minimally Invasive Biopsy Techniques Market, By Product Offered:

  • Tests
  • Kits & Consumables
  • Instruments

Minimally Invasive Biopsy Techniques Market, By Technique:

  • Liquid Biopsy
  • Optical Biopsy
  • Brush Biopsy
  • Pigmented Lesion Assays
  • Others

Minimally Invasive Biopsy Techniques Market, By Circulating Biomarker:

  • Circulating Tumor Cells (CTCs)
  • Cell Free DNA (cfDNA)
  • Circulating Tumor DNA (ctDNA)
  • Extracellular Vesicles
  • Others

Minimally Invasive Biopsy Techniques Market, By Application:

  • Clinical
  • Therapeutic

Minimally Invasive Biopsy Techniques Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Center
  • Academic & Research Institutions

Minimally Invasive Biopsy Techniques Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Minimally Invasive Biopsy Techniques Market.

Available Customizations:

Global Minimally Invasive Biopsy Techniques Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Minimally Invasive Biopsy Techniques Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
    • 5.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others)
    • 5.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others)
    • 5.2.4. By Application (Clinical, Therapeutic)
    • 5.2.5. By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Market Map

6. North America Minimally Invasive Biopsy Techniques Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Offered
    • 6.2.2. By Technique
    • 6.2.3. By Circulating Biomarker
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Offered
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Circulating Biomarker
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Offered
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Circulating Biomarker
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Offered
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Circulating Biomarker
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Minimally Invasive Biopsy Techniques Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Offered
    • 7.2.2. By Technique
    • 7.2.3. By Circulating Biomarker
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Offered
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Circulating Biomarker
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Offered
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Circulating Biomarker
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Offered
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Circulating Biomarker
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Offered
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Circulating Biomarker
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Offered
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Circulating Biomarker
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia Pacific Minimally Invasive Biopsy Techniques Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Offered
    • 8.2.2. By Technique
    • 8.2.3. By Circulating Biomarker
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Offered
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Circulating Biomarker
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Offered
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Circulating Biomarker
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Offered
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Circulating Biomarker
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Offered
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Circulating Biomarker
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Offered
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Circulating Biomarker
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Middle East & Africa Minimally Invasive Biopsy Techniques Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Offered
    • 9.2.2. By Technique
    • 9.2.3. By Circulating Biomarker
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Offered
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Circulating Biomarker
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Minimally Invasive Biopsy Techniques Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Offered
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Circulating Biomarker
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Offered
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Circulating Biomarker
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Minimally Invasive Biopsy Techniques Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Offered
    • 10.2.2. By Technique
    • 10.2.3. By Circulating Biomarker
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Offered
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Circulating Biomarker
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Minimally Invasive Biopsy Techniques Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Offered
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Circulating Biomarker
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Minimally Invasive Biopsy Techniques Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Offered
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Circulating Biomarker
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Minimally Invasive Biopsy Techniques Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. F. Hoffmann-La Roche AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. PerkinElmer Inc.
  • 15.4. QIAGEN NV
  • 15.5. Guardant Health, Inc.
  • 15.6. Veracyte, Inc.
  • 15.7. Myriad Genetics, Inc.
  • 15.8. Biocept, Inc.
  • 15.9. NeoGenomics Laboratories, Inc.
  • 15.10. Adaptive Biotechnologies Corporation

16. Strategic Recommendations

17. About Us & Disclaimer